Triple-Drug cocktail shows promise for untreated lung cancer
Disease control
Completed
This phase II trial tested a combination of two immunotherapy drugs (nivolumab and ipilimumab) plus chemotherapy (paclitaxel) in 46 people with untreated metastatic non-small cell lung cancer. The goal was to see if the mix could slow cancer growth and be safe. Results may point …
Phase: PHASE2 • Sponsor: Jeffrey Clarke • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC